BMO Capital Maintains Outperform on Celestica, Raises Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Thanos Moschopoulos has maintained an Outperform rating on Celestica (NYSE:CLS) and increased the price target from $27 to $32.
November 30, 2023 | 4:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BMO Capital analyst has reaffirmed an Outperform rating on Celestica and raised the price target to $32, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst typically signals a bullish perspective on the stock, suggesting that the analyst expects the stock to perform well in the near term. This can often lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100